- DKK189.85bn
- DKK211.39bn
- €4.16bn
Novonesis has 'runway for runaway growth' - MS starts at 'overweight'
Europe Research Roundup: De'Longhi SpA, Freenet AG, Johnson Matthey
Timeline: From insulin to Ozempic, history of Novo Nordisk's CEOs
Brief: Novonesis Q1 Adjusted EBITDA Up At EUR 412.8 Million
Novo Holdings nearly doubles earnings as Wegovy swells coffers (updated)
Coffers swelling on Wegovy sales, Novo Holdings doubles income and returns in 2024
Europe Research Roundup: Novonesis, Senior Plc, Whitbread
Brief: Novonesis - Executive Vice President Sold Shares In Co For Around DKK 4.3 Mln
Novonesis climbs on 2025 guidance, buy-back
DSM-Firmenich rises after it agrees to divest feed enzymes venture
Novonesis to buy DSM-Firmenich's stake in enzymes venture for $1.6 bln (updated)
Novonesis to buy DSM-Firmenich's stake in enzymes venture for $1.6 bln
Brief: Novonesis To Take Over Feed Enzyme Alliance
JPM ups EU chemicals on valuation despite uncertain macro outlook
Brief: Novonesis CFO Rainer Lehmann Buys 2,000 Shares In Co
Novonesis rises on strong revenue growth across segments
Brief: Novonesis Expects 20204 Organic Sales Growth At Upper End Of 7-8% Range
Brief: Novonesis Outlook FY Organic Growth 7-8%
Europe Research Roundup: Carnival, Kingfisher, Unite Group